MedPath

Clinical Evaluation of Siddha Medicine thuthuvelai chooranam for swasakasam (Bronchial asthma)

Phase 2
Conditions
Health Condition 1: J453- Mild persistent asthma
Registration Number
CTRI/2023/11/060017
Lead Sponsor
M.Anitha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cough with tenacious sputum, Dyspnoea, H/O Wheeze or without wheeze,Chest tightness,Peak expiratory flow rate below 60%

Exclusion Criteria

Chronic bronchitis

Bronchiectasis

Bronchogenic carcinoma

Pulmonary TB

Congestive cardiac failure

Bleeding disorders

Pregnancy and lactating mothers

Status asthmaticus

Diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome will be by assessing peak expiratory flow rate above 60%Timepoint: 48 days
Secondary Outcome Measures
NameTimeMethod
reduction in clinical symptoms like wheeze, dyspnoea and chest tightness.Timepoint: 48 days
© Copyright 2025. All Rights Reserved by MedPath